Global Lipid Contract Manufacturing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01240054

Publication Date:

January 11, 2024

Pages:

114

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Lipid Contract Manufacturing market size was valued at US$ 998.4 million in 2023. With growing demand in downstream market, the Lipid Contract Manufacturing is forecast to a readjusted size of US$ 928.8 million by 2030 with a CAGR of -1.0% during review period.
The research report highlights the growth potential of the global Lipid Contract Manufacturing market. Lipid Contract Manufacturing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lipid Contract Manufacturing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lipid Contract Manufacturing market.
Liposomes and lipid nanoparticles (LNPs) are similar by design, but slightly different in composition and function. Both are lipid nanoformulations and excellent drug delivery vehicles, transporting cargo of interest within a protective, outer layer of lipids. In application, however, LNPs can take a variety of forms.Innovators in the biopharmaceutical industry have developed a number of ways to improve/augment physiochemical properties and ultimately, the drug-like behavior of pharmacological substances. Amidst other alternatives, lipid nanoparticles and liposomes are the main type.Nanoparticle Drug Delivery Systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.Liposomes and Lipid Nanoparticles are delivery carriers, the primary lipids used to make liposomes or Lipid Nanoparticles are Phospholipids, Pegylated Lipids, Ionizable Lipids (Cationic / Anionic Lipids), Triglycerides, Sphingolipids, Neutral Lipids, etc. In our report, we mainly study the Liposomes and Lipid Nanoparticles (LNP) Contract Manufacturing as delivery carriers.
Global core lipid contract manufacturing companies include Merck KGaA, Exelead and Avanti Polar Lipids etc. The top 3 companies hold a share about 38%. North America is the largest market, with a share over 60%, followed by Europe and APAC with the share about 26% and 12%.
In terms of product, lipid nanoparticles is the largest segment with a share about 79%. And in terms of application, the largest application is commercial with a share about 67%, followed by clinical and preclinical.
Key Features:
The report on Lipid Contract Manufacturing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lipid Contract Manufacturing market. It may include historical data, market segmentation by Type (e.g., Liposomes, Lipid Nanoparticles), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lipid Contract Manufacturing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lipid Contract Manufacturing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lipid Contract Manufacturing industry. This include advancements in Lipid Contract Manufacturing technology, Lipid Contract Manufacturing new entrants, Lipid Contract Manufacturing new investment, and other innovations that are shaping the future of Lipid Contract Manufacturing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lipid Contract Manufacturing market. It includes factors influencing customer ' purchasing decisions, preferences for Lipid Contract Manufacturing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lipid Contract Manufacturing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lipid Contract Manufacturing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lipid Contract Manufacturing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lipid Contract Manufacturing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lipid Contract Manufacturing market.
Market Segmentation:
Lipid Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Liposomes
Lipid Nanoparticles
Segmentation by application
Preclinical
Clinical
Commercial
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lipid Contract Manufacturing Market Size 2019-2030
2.1.2 Lipid Contract Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lipid Contract Manufacturing Segment by Type
2.2.1 Liposomes
2.2.2 Lipid Nanoparticles
2.3 Lipid Contract Manufacturing Market Size by Type
2.3.1 Lipid Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lipid Contract Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Lipid Contract Manufacturing Segment by Application
2.4.1 Preclinical
2.4.2 Clinical
2.4.3 Commercial
2.5 Lipid Contract Manufacturing Market Size by Application
2.5.1 Lipid Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lipid Contract Manufacturing Market Size Market Share by Application (2019-2024)
3 Lipid Contract Manufacturing Market Size by Player
3.1 Lipid Contract Manufacturing Market Size Market Share by Players
3.1.1 Global Lipid Contract Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Lipid Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Lipid Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lipid Contract Manufacturing by Regions
4.1 Lipid Contract Manufacturing Market Size by Regions (2019-2024)
4.2 Americas Lipid Contract Manufacturing Market Size Growth (2019-2024)
4.3 APAC Lipid Contract Manufacturing Market Size Growth (2019-2024)
4.4 Europe Lipid Contract Manufacturing Market Size Growth (2019-2024)
4.5 Middle East & Africa Lipid Contract Manufacturing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Lipid Contract Manufacturing Market Size by Country (2019-2024)
5.2 Americas Lipid Contract Manufacturing Market Size by Type (2019-2024)
5.3 Americas Lipid Contract Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lipid Contract Manufacturing Market Size by Region (2019-2024)
6.2 APAC Lipid Contract Manufacturing Market Size by Type (2019-2024)
6.3 APAC Lipid Contract Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lipid Contract Manufacturing by Country (2019-2024)
7.2 Europe Lipid Contract Manufacturing Market Size by Type (2019-2024)
7.3 Europe Lipid Contract Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lipid Contract Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Lipid Contract Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Lipid Contract Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lipid Contract Manufacturing Market Forecast
10.1 Global Lipid Contract Manufacturing Forecast by Regions (2025-2030)
10.1.1 Global Lipid Contract Manufacturing Forecast by Regions (2025-2030)
10.1.2 Americas Lipid Contract Manufacturing Forecast
10.1.3 APAC Lipid Contract Manufacturing Forecast
10.1.4 Europe Lipid Contract Manufacturing Forecast
10.1.5 Middle East & Africa Lipid Contract Manufacturing Forecast
10.2 Americas Lipid Contract Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Lipid Contract Manufacturing Market Forecast
10.2.2 Canada Lipid Contract Manufacturing Market Forecast
10.2.3 Mexico Lipid Contract Manufacturing Market Forecast
10.2.4 Brazil Lipid Contract Manufacturing Market Forecast
10.3 APAC Lipid Contract Manufacturing Forecast by Region (2025-2030)
10.3.1 China Lipid Contract Manufacturing Market Forecast
10.3.2 Japan Lipid Contract Manufacturing Market Forecast
10.3.3 Korea Lipid Contract Manufacturing Market Forecast
10.3.4 Southeast Asia Lipid Contract Manufacturing Market Forecast
10.3.5 India Lipid Contract Manufacturing Market Forecast
10.3.6 Australia Lipid Contract Manufacturing Market Forecast
10.4 Europe Lipid Contract Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Lipid Contract Manufacturing Market Forecast
10.4.2 France Lipid Contract Manufacturing Market Forecast
10.4.3 UK Lipid Contract Manufacturing Market Forecast
10.4.4 Italy Lipid Contract Manufacturing Market Forecast
10.4.5 Russia Lipid Contract Manufacturing Market Forecast
10.5 Middle East & Africa Lipid Contract Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Lipid Contract Manufacturing Market Forecast
10.5.2 South Africa Lipid Contract Manufacturing Market Forecast
10.5.3 Israel Lipid Contract Manufacturing Market Forecast
10.5.4 Turkey Lipid Contract Manufacturing Market Forecast
10.5.5 GCC Countries Lipid Contract Manufacturing Market Forecast
10.6 Global Lipid Contract Manufacturing Forecast by Type (2025-2030)
10.7 Global Lipid Contract Manufacturing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Information
11.1.2 Precision NanoSystems Lipid Contract Manufacturing Product Offered
11.1.3 Precision NanoSystems Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Precision NanoSystems Main Business Overview
11.1.5 Precision NanoSystems Latest Developments
11.2 Evonik
11.2.1 Evonik Company Information
11.2.2 Evonik Lipid Contract Manufacturing Product Offered
11.2.3 Evonik Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Evonik Main Business Overview
11.2.5 Evonik Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Lipid Contract Manufacturing Product Offered
11.3.3 Merck KGaA Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Information
11.4.2 Genevant Sciences Lipid Contract Manufacturing Product Offered
11.4.3 Genevant Sciences Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Genevant Sciences Main Business Overview
11.4.5 Genevant Sciences Latest Developments
11.5 Exelead
11.5.1 Exelead Company Information
11.5.2 Exelead Lipid Contract Manufacturing Product Offered
11.5.3 Exelead Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Exelead Main Business Overview
11.5.5 Exelead Latest Developments
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Information
11.6.2 Avanti Polar Lipids Lipid Contract Manufacturing Product Offered
11.6.3 Avanti Polar Lipids Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Avanti Polar Lipids Main Business Overview
11.6.5 Avanti Polar Lipids Latest Developments
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Information
11.7.2 Nippon Fine Chemical Lipid Contract Manufacturing Product Offered
11.7.3 Nippon Fine Chemical Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Nippon Fine Chemical Main Business Overview
11.7.5 Nippon Fine Chemical Latest Developments
11.8 Lipoid
11.8.1 Lipoid Company Information
11.8.2 Lipoid Lipid Contract Manufacturing Product Offered
11.8.3 Lipoid Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lipoid Main Business Overview
11.8.5 Lipoid Latest Developments
11.9 Polymun Scientific
11.9.1 Polymun Scientific Company Information
11.9.2 Polymun Scientific Lipid Contract Manufacturing Product Offered
11.9.3 Polymun Scientific Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Polymun Scientific Main Business Overview
11.9.5 Polymun Scientific Latest Developments
11.10 Corden Pharma
11.10.1 Corden Pharma Company Information
11.10.2 Corden Pharma Lipid Contract Manufacturing Product Offered
11.10.3 Corden Pharma Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Corden Pharma Main Business Overview
11.10.5 Corden Pharma Latest Developments
11.11 Acuitas Therapeutics
11.11.1 Acuitas Therapeutics Company Information
11.11.2 Acuitas Therapeutics Lipid Contract Manufacturing Product Offered
11.11.3 Acuitas Therapeutics Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Acuitas Therapeutics Main Business Overview
11.11.5 Acuitas Therapeutics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂